This is an open-label randomized study looking at an 8-week Mindfulness-Based Stress Reduction (MBSR) curriculum vs. an 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention for frontline healthcare providers struggling with symptoms of depression and burnout associated with the SARS-CoV-2 pandemic.
Status
Not yet recruiting
Results Published
Start date
01 January 2023
End date
01 January 2024
Chance of happening
100%
Design
Open
Type
Interventional
Generation
First
Participants
24
Sex
All
Age
25- 99
Therapy
Yes
Trial Details
This project is an open-label randomized study looking at an 8-week Mindfulness-Based Stress Reduction (MBSR) curriculum vs. an 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention for frontline healthcare providers struggling with symptoms of depression and burnout associated with the SARS-CoV-2 pandemic. Following consenting and enrollment a total of 24 participants will be randomized to receive either an 8-week MBSR curriculum or the same 8-week MBSR curriculum + a group psilocybin-assisted psychotherapy intervention. The group psilocybin-assisted psychotherapy intervention will involve 3 group preparatory sessions (2 hours each), a single 8 hour group psilocybin administration session with a 1:1 therapist to participant ratio (25mg psilocybin dose), and 3 group integration sessions (2 hours each).NCT Number NCT05557643
Sponsors & Collaborators
Heffter Research InstituteThe Heffter Research Institute has been advancing psychedelics (psilocybin) as medicines since 1993.
Usona Institute
The Usona Institute was founded by Bill Linton and Malynn Utzinger. Currently, 18 people are associated with it. The institute is a non-profit that sponsors psilocybin research (and is funded by sponsors/philanthropists).
University of Utah
Research with psychedelics is underway at the University of Utah. At the university, researchers are working with the Usona Institute exploring psilocybin-assisted group therapy in patients with cancer.